EyePoint, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from EyePoint, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 7.9 times its market value (net cash). Higher than almost all Healthcare companies in United States.
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $26 per $100 of sales comes from others' credit, against $30 tied up three years earlier. Less money tied up than 96% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-33.7×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 66% of Healthcare companies in United States.
Cash Locked Ratio
−$26Money owed to suppliers is larger than money owed by customers plus stock: $26 per $100 of sales comes from others' credit, against $30 tied up three years earlier.
Less money tied up than 96% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 24%
Sales fell 24% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-24% / +102%In 3 years sales changed by -24% while total assets changed by +102%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
7.9× cashCash, after subtracting all debt, is 7.9 times its market value (net cash).
Higher than almost all Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
EyePoint, Inc. made a loss over the last year. EyePoint, Inc. owes $0.27 for every $1 it owns. EyePoint, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossEyePoint, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.22The share price is 0.22 times EyePoint, Inc.'s book value per share, lower than 98% of Healthcare companies in United States.
Market cap
$36 MThe total market value of all of EyePoint, Inc.'s shares at today's price (share price × number of shares), smaller than 78% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$166 MWhat EyePoint, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.98Net worth divided by the number of shares. The share price of $0.43 is 0.2 times this, which is the P/B above.
Return on equity (ROE)
-148.7%EyePoint, Inc. lost 148.7% of its shareholders' money over the last year, lower than 79% of Healthcare companies in United States.
Owes vs Owns
0.27×EyePoint, Inc. owes $0.27 for every $1 it owns (low), lower than 63% of Healthcare companies in United States.
Dividend yield
NoneEyePoint, Inc. does not currently pay a dividend.
Revenue growth
-28%Revenue fell 28% in the year to Dec 2025, and shrank 9% a year on average over 3 years.
Profit growth
LossEyePoint, Inc. made a loss in each of the last two years.
Profit margin
-739.4%EyePoint, Inc. lost $739 for every $100 of revenue.
Interest cover
Not coveredEyePoint, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashEyePoint, Inc. held $285 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For EyePoint, Inc.: $36 M ÷ $166 M (30 Jun 2026) = 0.2.
What is EyePoint, Inc.'s return on equity?
EyePoint, Inc. lost 148.7% of its shareholders' money over the last year, lower than 79% of Healthcare companies in United States.
How much does EyePoint, Inc. owe compared with what it owns?
EyePoint, Inc. owes $0.27 for every $1 it owns (low), lower than 63% of Healthcare companies in United States.
Does EyePoint, Inc. pay a dividend?
No. EyePoint, Inc. does not currently pay a dividend.
Is EyePoint, Inc.'s revenue growing?
Revenue fell 28% in the year to Dec 2025, and shrank 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.